Balaji Amines Reports Q1FY26 Results: Revenue Up 2% QoQ, Margins Under Pressure

1 min read     Updated on 05 Aug 2025, 08:52 PM
scanx
Reviewed by
Riya DeyScanX News Team
whatsapptwittershare
Overview

Balaji Amines reported consolidated revenue of ₹367.00 crore for Q1FY26, a 2% increase from Q4FY25 but a 7% year-on-year decline. Total volumes increased to 27,570 MT. Despite revenue growth, profitability metrics showed pressure with EBITDA at ₹64.00 crore and PAT at ₹37.00 crore, both declining year-on-year. The company continues to progress on expansion projects including a DME plant, NMM facility, and upgraded Acetonitrile plant. Balaji Amines commissioned an 8 MW DC solar power plant in April 2025 for sustainability and cost reduction. The company maintains a zero-debt status on a standalone basis.

15952927

*this image is generated using AI for illustrative purposes only.

Balaji Amines , a leading manufacturer of aliphatic amines and specialty chemicals, has released its financial results for the first quarter of fiscal year 2026 (Q1FY26), showing mixed performance with revenue growth but margin pressure.

Revenue and Volume Growth

The company reported consolidated revenue of ₹367.00 crore for Q1FY26, marking a 2% increase from ₹361.00 crore in Q4FY25. However, this figure represents a 7% year-on-year decline from ₹393.00 crore in Q1FY25. Total volumes increased to 27,570 MT in Q1FY26 from 25,871 MT in the previous quarter, indicating improved demand.

Product-wise Performance

The volume breakdown for Q1FY26 was as follows:

  • Amines: 7,573 MT
  • Amines Derivatives: 8,108 MT
  • Specialty Chemicals: 11,889 MT

Profitability Under Pressure

Despite the revenue growth, the company's profitability metrics showed signs of pressure:

Metric Q1FY26 Q4FY25 Q1FY25 QoQ Change YoY Change
EBITDA (₹ crore) 64.00 68.00 74.00 -5.90% -13.50%
EBITDA Margin 17.00% 19.00% 19.00% -2 pp -2 pp
PAT (₹ crore) 37.00 40.00 46.00 -7.50% -19.60%
PAT Margin 10.00% 11.00% 12.00% -1 pp -2 pp

The company's diluted Earnings Per Share (EPS) for Q1FY26 stood at ₹11.73, compared to ₹12.36 in Q4FY25.

Expansion Projects and Future Outlook

Balaji Amines continues to progress on multiple expansion projects:

  1. Dimethyl Ether (DME) Plant: Expected to be commissioned in FY2025-26.
  2. N-Methyl Morpholine (NMM) Facility: 5,000 TPA capacity, scheduled for commissioning in FY2025-26.
  3. Upgraded Acetonitrile Plant: Planned for commissioning in FY2026-27.

The company's subsidiary, Balaji Speciality Chemicals, has received Mega Project status from the Maharashtra government for its ₹750.00 crore expansion. This project includes products like Hydrogen Cyanide and EDTA, with commissioning planned for FY2026-27.

Sustainable Initiatives

In line with its commitment to sustainability and cost reduction, Balaji Amines commissioned an 8 MW DC (6 MW AC) solar power plant in April 2025. This initiative is expected to substantially reduce power costs across all plants and lower the company's carbon footprint.

Financial Position

The company maintains a zero-debt status on a standalone basis, showcasing its strong financial discipline.

Balaji Amines' management remains focused on its expansion strategy, aiming to strengthen its market position in high-value derivatives and specialty chemicals. The company's ongoing projects and sustainable initiatives are expected to drive long-term growth and operational efficiency.

Historical Stock Returns for Balaji Amines

1 Day5 Days1 Month6 Months1 Year5 Years
+2.05%+1.17%-1.43%+29.21%-33.58%+76.89%
Balaji Amines
View in Depthredirect
like16
dislike

Balaji Amines Reports Q1 FY26 Results with Standalone Profit of Rs 39.80 Crore

1 min read     Updated on 02 Aug 2025, 08:22 PM
scanx
Reviewed by
Radhika SahaniScanX News Team
whatsapptwittershare
Overview

Balaji Amines, a leading specialty chemicals manufacturer, announced its Q1 FY26 financial results. Standalone revenue from operations was Rs 319.38 crore, down 4.04% year-over-year. Profit After Tax stood at Rs 39.80 crore, a 1.78% decrease. Consolidated revenue was Rs 358.34 crore with a PAT of Rs 38.00 crore. The Amines & Speciality Chemicals segment generated Rs 316.66 crore in revenue, while the Hotel Division contributed Rs 10.27 crore. Despite slight decreases, the company maintained a strong financial position and profitability.

15691957

*this image is generated using AI for illustrative purposes only.

Balaji Amines , a leading manufacturer of specialty chemicals, has announced its financial results for the first quarter of the fiscal year 2025-26 (Q1 FY26), demonstrating robust performance across its business segments.

Standalone Financial Highlights

The company reported impressive standalone financial results for Q1 FY26:

Particulars (Rs in Crore) Q1 FY26 Q1 FY25 YoY Change
Revenue from Operations 319.38 332.84 -4.04%
Profit Before Tax 52.34 54.61 -4.16%
Profit After Tax 39.80 40.52 -1.78%
Basic EPS (Rs) 12.28 12.51 -1.84%

Despite a slight decrease in revenue and profit compared to the same quarter last year, Balaji Amines has maintained a strong financial position. The company's revenue from operations stood at Rs 319.38 crore, while profit after tax reached Rs 39.80 crore for the quarter.

Consolidated Performance

On a consolidated basis, Balaji Amines reported:

  • Revenue from operations of Rs 358.34 crore
  • Profit after tax attributable to owners of Rs 38.00 crore
  • Basic earnings per share of Rs 11.73

Segment-wise Performance

Balaji Amines operates through two main segments:

Amines & Speciality Chemicals

This segment generated revenue of Rs 316.66 crore and a profit before interest and tax of Rs 48.38 crore on a standalone basis.

Hotel Division

The hotel division contributed Rs 10.27 crore to the revenue and recorded a profit before interest and tax of Rs 3.90 crore.

Management Commentary

D Ram Reddy, Managing Director of Balaji Amines Limited, stated, "We are pleased with our performance in the first quarter of FY26. Despite challenging market conditions, we have maintained profitability and continued to focus on our core specialty chemicals business."

Audit Review

The financial results were reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on August 2, 2025. M. Anandam & Co., Chartered Accountants, the company's statutory auditors, have provided an unmodified opinion on both standalone and consolidated financial statements.

Future Outlook

While the company has not provided specific guidance for the future, the steady performance in Q1 FY26 suggests that Balaji Amines is well-positioned to navigate the current market environment. The company's focus on specialty chemicals and its diversified product portfolio are expected to contribute to its resilience in the coming quarters.

Historical Stock Returns for Balaji Amines

1 Day5 Days1 Month6 Months1 Year5 Years
+2.05%+1.17%-1.43%+29.21%-33.58%+76.89%
Balaji Amines
View in Depthredirect
like16
dislike
More News on Balaji Amines
Explore Other Articles
1,521.00
+30.60
(+2.05%)